Pediatric Neurology
Volume 33, Issue 4 , Pages 267-271, October 2005

School Performance in Early and Continuously Treated Phenylketonuria

  • Rosa Gassió, MD

      Affiliations

    • PKU Follow-up Unit: Neuropediatrics Department, Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain.
  • ,
  • Eugenia Fusté, MSC

      Affiliations

    • PKU Follow-up Unit: Psychology Department, Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain.
  • ,
  • Anna López-Sala, MSC

      Affiliations

    • PKU Follow-up Unit: Neuropediatrics Department, Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain.
  • ,
  • Rafael Artuch, MD, PhD

      Affiliations

    • PKU Follow-up Unit: Biochemistry Department, Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain.
  • ,
  • María Antonia Vilaseca, PhD

      Affiliations

    • PKU Follow-up Unit: Biochemistry Department, Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain.
  • ,
  • Jaume Campistol, MD, PhD

      Affiliations

    • Corresponding Author InformationCommunications should be addressed to: Dr. Campistol; Neuropediatrics Department; Hospital Sant Joan de Déu; Passeig Sant Joan de Déu no. 2; 08950-Esplugues de Llobregat; Barcelona, Spain.
    • PKU Follow-up Unit: Neuropediatrics Department, Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain.

Received 19 September 2004; accepted 9 May 2005.

This study investigated the relationship between school performance, cognitive functions, and dietary control in a group of 26 early and continuously treated phenylketonuric patients, in comparison with 21 sex- and age-matched control subjects. The cognitive functions study included intelligence measurement, visual and auditory memory and auditory verbal learning abilities, attention, visuospatial, fine motor, language, and executive functions. Participants were asked about school performance. The indexes of dietary control for the first 6 years of life and for the 6 months before the study were calculated. The intelligence score was significantly lower in phenylketonuric patients (P < 0.0001). The percentage of patients with attention problems (P = 0.02), fine motor (P = 0.001) and executive dysfunctions (P = 0.013) was significantly higher than that for control subjects. Patients had more school problems than controls (P = 0.028). Intelligence score was also significantly lower in these patients (P = 0.046). The index of dietary control for the last 6 months was significantly higher than the index for the first 6 years of life, but only in the patients with school problems (P = 0.033). In conclusion, phenylketonuric patients presented more school problems than control subjects, probably related to the disturbed cognitive functions observed. The index of dietary control for the last 6 months yielded a close relationship with school performance.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0887-8994(05)00255-9

doi:10.1016/j.pediatrneurol.2005.05.003

Pediatric Neurology
Volume 33, Issue 4 , Pages 267-271, October 2005